{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T19:19:53Z","timestamp":1757618393087,"version":"3.44.0"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T00:00:00Z","timestamp":1750723200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T00:00:00Z","timestamp":1750723200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Innere Medizin"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1007\/s00108-025-01911-7","type":"journal-article","created":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T12:16:35Z","timestamp":1750767395000},"page":"666-677","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Zielorgan Lunge: Vielfalt der fibrotischen Lungenerkrankungen","Target organ the lungs: diversity of fibrotic pulmonary diseases"],"prefix":"10.1007","volume":"66","author":[{"given":"Gabriela","family":"Leuschner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00fcrgen","family":"Behr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,6,24]]},"reference":[{"issue":"25","key":"1911_CR1","doi-asserted-by":"publisher","first-page":"2485","DOI":"10.1056\/NEJMc2031135","volume":"383","author":"M Wijsenbeek","year":"2020","unstructured":"Wijsenbeek\u00a0M, Cottin\u00a0V (2020) Spectrum of fibrotic lung diseases. Reply. N\u00a0Engl J Med 383(25):2485\u20132486","journal-title":"N Engl J Med"},{"key":"1911_CR2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22168952","author":"AV Samarelli","year":"2021","unstructured":"Samarelli\u00a0AV, Tonelli\u00a0R, Marchioni\u00a0A, Bruzzi\u00a0G, Gozzi\u00a0F, Andrisani\u00a0D et\u00a0al (2021) Fibrotic idiopathic interstitial lung disease: the molecular and cellular key players. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms22168952","journal-title":"Int J Mol Sci"},{"issue":"10354","key":"1911_CR3","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1016\/S0140-6736(22)01052-2","volume":"400","author":"M Wijsenbeek","year":"2022","unstructured":"Wijsenbeek\u00a0M, Suzuki\u00a0A, Maher\u00a0TM (2022) Interstitial lung diseases. Lancet 400(10354):769\u2013786","journal-title":"Lancet"},{"key":"1911_CR4","doi-asserted-by":"publisher","DOI":"10.1159\/000540856","author":"J Behr","year":"2024","unstructured":"Behr\u00a0J, Bonella\u00a0F, Frye\u00a0BC, Gunther\u00a0A, Hagmeyer\u00a0L, Henes\u00a0J et\u00a0al (2024) Pharmacological treatment of idiopathic pulmonary fibrosis (update) and progressive pulmonary fibroses: S2k guideline of the German respiratory society. Respiration. https:\/\/doi.org\/10.1159\/000540856","journal-title":"Respiration"},{"key":"1911_CR5","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.02419-2016","author":"B Duchemann","year":"2017","unstructured":"Duchemann\u00a0B, Annesi-Maesano\u00a0I, Jacobe de Naurois\u00a0C, Sanyal\u00a0S, Brillet\u00a0PY, Brauner\u00a0M et\u00a0al (2017) Prevalence and incidence of interstitial lung diseases in a\u00a0multi-ethnic county of Greater Paris. Eur Respir\u00a0J. https:\/\/doi.org\/10.1183\/13993003.02419-2016","journal-title":"Eur Respir J"},{"issue":"1","key":"1911_CR6","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1186\/s12931-021-01791-z","volume":"22","author":"TM Maher","year":"2021","unstructured":"Maher\u00a0TM, Bendstrup\u00a0E, Dron\u00a0L, Langley\u00a0J, Smith\u00a0G, Khalid\u00a0JM et\u00a0al (2021) Global incidence and prevalence of idiopathic pulmonary fibrosis. Respir Res 22(1):197","journal-title":"Respir Res"},{"issue":"51","key":"1911_CR7","first-page":"875","volume":"110","author":"J Behr","year":"2013","unstructured":"Behr\u00a0J (2013) The diagnosis and treatment of idiopathic pulmonary fibrosis. Dtsch \u00c4rztebl Int 110(51):875\u2013881","journal-title":"Dtsch \u00c4rztebl Int"},{"issue":"7193","key":"1911_CR8","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1038\/nature07039","volume":"453","author":"GC Gurtner","year":"2008","unstructured":"Gurtner\u00a0GC, Werner\u00a0S, Barrandon\u00a0Y, Longaker\u00a0MT (2008) Wound repair and regeneration. Nature 453(7193):314\u2013321","journal-title":"Nature"},{"issue":"7","key":"1911_CR9","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1084\/jem.20110551","volume":"208","author":"TA Wynn","year":"2011","unstructured":"Wynn\u00a0TA (2011) Integrating mechanisms of pulmonary fibrosis. J\u00a0Exp Med 208(7):1339\u20131350","journal-title":"J Exp Med"},{"issue":"7","key":"1911_CR10","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1016\/S2213-2600(20)30168-5","volume":"8","author":"H Hatabu","year":"2020","unstructured":"Hatabu\u00a0H, Hunninghake\u00a0GM, Richeldi\u00a0L, Brown\u00a0KK, Wells\u00a0AU, Remy-Jardin\u00a0M et\u00a0al (2020) Interstitial lung abnormalities detected incidentally on CT: a\u00a0position paper from the Fleischner society. Lancet Respir Med 8(7):726\u2013737","journal-title":"Lancet Respir Med"},{"key":"1911_CR11","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0206-2021","author":"S Tomassetti","year":"2022","unstructured":"Tomassetti\u00a0S, Poletti\u00a0V, Ravaglia\u00a0C, Sverzellati\u00a0N, Piciucchi\u00a0S, Cozzi\u00a0D et\u00a0al (2022) Incidental discovery of interstitial lung disease: diagnostic approach, surveillance and perspectives. Eur Respir Rev. https:\/\/doi.org\/10.1183\/16000617.0206-2021","journal-title":"Eur Respir Rev"},{"issue":"5","key":"1911_CR12","doi-asserted-by":"publisher","first-page":"e44","DOI":"10.1164\/rccm.201807-1255ST","volume":"198","author":"G Raghu","year":"2018","unstructured":"Raghu\u00a0G, Remy-Jardin\u00a0M, Myers\u00a0JL, Richeldi\u00a0L, Ryerson\u00a0CJ, Lederer\u00a0DJ et\u00a0al (2018) Diagnosis of idiopathic pulmonary fibrosis. An official ATS\/ERS\/JRS\/ALAT clinical practice guideline. Am J Respir Crit Care Med 198(5):e44\u2013e68","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"1911_CR13","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1055\/a-1120-3531","volume":"74","author":"J Behr","year":"2020","unstructured":"Behr\u00a0J, Gunther\u00a0A, Bonella\u00a0F, Dinkel\u00a0J, Fink\u00a0L, Geiser\u00a0T et\u00a0al (2020) German guideline for idiopathic pulmonary fibrosis. Pneumologie 74(5):263\u2013293","journal-title":"Pneumologie"},{"issue":"6","key":"1911_CR14","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1055\/s-0044-100207","volume":"72","author":"M Kreuter","year":"2018","unstructured":"Kreuter\u00a0M, Ochmann\u00a0U, Koschel\u00a0D, Behr\u00a0J, Bonella\u00a0F, Claussen\u00a0M et\u00a0al (2018) DGP interstitial lung disease patient questionnaire. Pneumologie 72(6):446\u2013457","journal-title":"Pneumologie"},{"key":"1911_CR15","doi-asserted-by":"publisher","DOI":"10.1159\/000543675","author":"D Koschel","year":"2024","unstructured":"Koschel\u00a0D, Behr\u00a0J, Berger\u00a0M, Bonella\u00a0F, Hamer\u00a0O, Joest\u00a0M et\u00a0al (2024) Diagnosis and treatment of hypersensitivity pneumonitis\u2014S2k guideline of the German respiratory society and the German society for allergology and clinical immunology. Pneumologie. https:\/\/doi.org\/10.1159\/000543675","journal-title":"Pneumologie"},{"issue":"5","key":"1911_CR16","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1055\/a-2017-8971","volume":"77","author":"M Kreuter","year":"2023","unstructured":"Kreuter\u00a0M, Behr\u00a0J, Bonella\u00a0F, Costabel\u00a0U, Gerber\u00a0A, Hamer\u00a0OW et\u00a0al (2023) Consensus guideline on the interdisciplinary diagnosis of interstitial lung diseases. Pneumologie 77(5):269\u2013302","journal-title":"Pneumologie"},{"issue":"19","key":"1911_CR17","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1056\/NEJMra1705751","volume":"378","author":"DJ Lederer","year":"2018","unstructured":"Lederer\u00a0DJ, Martinez\u00a0FJ (2018) Idiopathic pulmonary fibrosis. N\u00a0Engl J Med 378(19):1811\u20131823","journal-title":"N Engl J Med"},{"key":"1911_CR18","first-page":"152","volume":"118","author":"M Kreuter","year":"2021","unstructured":"Kreuter\u00a0M, Ladner\u00a0UM, Costabel\u00a0U, Jonigk\u00a0D, Heussel\u00a0CP (2021) The diagnosis and treatment of pulmonary fibrosis. Dtsch \u00c4rztebl Int 118:152\u2013162","journal-title":"Dtsch \u00c4rztebl Int"},{"issue":"5","key":"1911_CR19","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1016\/j.chest.2018.12.011","volume":"155","author":"A Adegunsoye","year":"2019","unstructured":"Adegunsoye\u00a0A, Vij\u00a0R, Noth\u00a0I (2019) Integrating genomics into management of fibrotic interstitial lung disease. Chest 155(5):1026\u20131040","journal-title":"Chest"},{"issue":"23","key":"1911_CR20","doi-asserted-by":"publisher","first-page":"2209","DOI":"10.1056\/NEJMoa1801562","volume":"379","author":"PA Juge","year":"2018","unstructured":"Juge\u00a0PA, Lee\u00a0JS, Ebstein\u00a0E, Furukawa\u00a0H, Dobrinskikh\u00a0E, Gazal\u00a0S et\u00a0al (2018) MUC5B promoter variant and rheumatoid arthritis with interstitial lung disease. N\u00a0Engl J Med 379(23):2209\u20132219","journal-title":"N Engl J Med"},{"issue":"9","key":"1911_CR21","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1164\/rccm.201902-0360OC","volume":"200","author":"B Ley","year":"2019","unstructured":"Ley\u00a0B, Torgerson\u00a0DG, Oldham\u00a0JM, Adegunsoye\u00a0A, Liu\u00a0S, Li\u00a0J et\u00a0al (2019) Rare protein-altering telomere-related gene variants in patients with chronic hypersensitivity pneumonitis. Am J Respir Crit Care Med 200(9):1154\u20131163","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"1911_CR22","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1111\/resp.12553","volume":"20","author":"C Neurohr","year":"2015","unstructured":"Neurohr\u00a0C, Behr\u00a0J (2015) Changes in the current classification of IIP: a\u00a0critical review. Respirology 20(5):699\u2013704","journal-title":"Respirology"},{"issue":"2","key":"1911_CR23","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1111\/resp.12674","volume":"21","author":"EA Belloli","year":"2016","unstructured":"Belloli\u00a0EA, Beckford\u00a0R, Hadley\u00a0R, Flaherty\u00a0KR (2016) Idiopathic non-specific interstitial pneumonia. Respirology 21(2):259\u2013268","journal-title":"Respirology"},{"issue":"1","key":"1911_CR24","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1164\/ajrccm.157.1.9704130","volume":"157","author":"JA Bjoraker","year":"1998","unstructured":"Bjoraker\u00a0JA, Ryu\u00a0JH, Edwin\u00a0MK, Myers\u00a0JL, Tazelaar\u00a0HD, Schroeder\u00a0DR et\u00a0al (1998) Prognostic significance of histopathologic subsets in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 157(1):199\u2013203","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"1911_CR25","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1183\/09031936.00148613","volume":"45","author":"H Nunes","year":"2015","unstructured":"Nunes\u00a0H, Schubel\u00a0K, Piver\u00a0D, Magois\u00a0E, Feuillet\u00a0S, Uzunhan\u00a0Y et\u00a0al (2015) Nonspecific interstitial pneumonia: survival is influenced by the underlying cause. Eur Respir\u00a0J 45(3):746\u2013755","journal-title":"Eur Respir J"},{"issue":"1","key":"1911_CR26","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1186\/s12931-017-0686-7","volume":"18","author":"SH Lee","year":"2017","unstructured":"Lee\u00a0SH, Park\u00a0MS, Kim\u00a0SY, Kim\u00a0DS, Kim\u00a0YW, Chung\u00a0MP et\u00a0al (2017) Factors affecting treatment outcome in patients with idiopathic nonspecific interstitial pneumonia: a\u00a0nationwide cohort study. Respir Res 18(1):204","journal-title":"Respir Res"},{"issue":"7","key":"1911_CR27","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1513\/AnnalsATS.201801-067OC","volume":"15","author":"SA Guler","year":"2018","unstructured":"Guler\u00a0SA, Ellison\u00a0K, Algamdi\u00a0M, Collard\u00a0HR, Ryerson\u00a0CJ (2018) Heterogeneity in unclassifiable interstitial lung disease. A\u00a0systematic review and meta-analysis. Ann Am Thorac Soc 15(7):854\u2013863","journal-title":"Ann Am Thorac Soc"},{"issue":"3","key":"1911_CR28","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1183\/09031936.00131912","volume":"42","author":"CJ Ryerson","year":"2013","unstructured":"Ryerson\u00a0CJ, Urbania\u00a0TH, Richeldi\u00a0L, Mooney\u00a0JJ, Lee\u00a0JS, Jones\u00a0KD et\u00a0al (2013) Prevalence and prognosis of unclassifiable interstitial lung disease. Eur Respir\u00a0J 42(3):750\u2013757","journal-title":"Eur Respir J"},{"key":"1911_CR29","doi-asserted-by":"publisher","DOI":"10.1002\/art.38733","author":"PA Juge","year":"2021","unstructured":"Juge\u00a0PA, Lee\u00a0JS, Lau\u00a0J, Kawano-Dourado\u00a0L, Rojas Serrano\u00a0J, Sebastiani\u00a0M et\u00a0al (2021) Methotrexate and rheumatoid arthritis associated interstitial lung disease. Eur Respir\u00a0J. https:\/\/doi.org\/10.1002\/art.38733","journal-title":"Eur Respir J"},{"issue":"4","key":"1911_CR30","doi-asserted-by":"publisher","first-page":"e94775","DOI":"10.1371\/journal.pone.0094775","volume":"9","author":"M Kono","year":"2014","unstructured":"Kono\u00a0M, Nakamura\u00a0Y, Enomoto\u00a0N, Hashimoto\u00a0D, Fujisawa\u00a0T, Inui\u00a0N et\u00a0al (2014) Usual interstitial pneumonia preceding collagen vascular disease: a\u00a0retrospective case control study of patients initially diagnosed with idiopathic pulmonary fibrosis. PLoS One 9(4):e94775","journal-title":"PLoS One"},{"key":"1911_CR31","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0210-2022","author":"GM Joy","year":"2023","unstructured":"Joy\u00a0GM, Arbiv\u00a0OA, Wong\u00a0CK, Lok\u00a0SD, Adderley\u00a0NA, Dobosz\u00a0KM et\u00a0al (2023) Prevalence, imaging patterns and risk factors of interstitial lung disease in connective tissue disease: a\u00a0systematic review and meta-analysis. Eur Respir Rev. https:\/\/doi.org\/10.1183\/16000617.0210-2022","journal-title":"Eur Respir Rev"},{"issue":"10","key":"1911_CR32","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1136\/ard.2009.114264","volume":"69","author":"AJ Tyndall","year":"2010","unstructured":"Tyndall\u00a0AJ, Bannert\u00a0B, Vonk\u00a0M, Airo\u00a0P, Cozzi\u00a0F, Carreira\u00a0PE et\u00a0al (2010) Causes and risk factors for death in systemic sclerosis: a\u00a0study from the EULAR scleroderma trials and research (EUSTAR) database. Ann Rheum Dis 69(10):1809\u20131815","journal-title":"Ann Rheum Dis"},{"issue":"137","key":"1911_CR33","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1183\/16000617.00002915","volume":"24","author":"S Cappelli","year":"2015","unstructured":"Cappelli\u00a0S, Bellando Randone\u00a0S, Camiciottoli\u00a0G, De Paulis\u00a0A, Guiducci\u00a0S, Matucci-Cerinic\u00a0M (2015) Interstitial lung disease in systemic sclerosis: where do we stand? Eur Respir Rev 24(137):411\u2013419","journal-title":"Eur Respir Rev"},{"issue":"1","key":"1911_CR34","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.chest.2021.02.026","volume":"160","author":"CT Lee","year":"2021","unstructured":"Lee\u00a0CT, Adegunsoye\u00a0A, Chung\u00a0JH, Ventura\u00a0IB, Jablonski\u00a0R, Montner\u00a0S et\u00a0al (2021) Characteristics and prevalence of domestic and occupational Inhalational exposures across interstitial lung diseases. Chest 160(1):209\u2013218","journal-title":"Chest"},{"issue":"2","key":"1911_CR35","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1148\/radiol.2442060640","volume":"244","author":"H Sahin","year":"2007","unstructured":"Sahin\u00a0H, Brown\u00a0KK, Curran-Everett\u00a0D, Hale\u00a0V, Cool\u00a0CD, Vourlekis\u00a0JS et\u00a0al (2007) Chronic hypersensitivity pneumonitis: CT features comparison with pathologic evidence of fibrosis and survival. Radiology 244(2):591\u2013598","journal-title":"Radiology"},{"issue":"4","key":"1911_CR36","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1164\/rccm.201203-0513CI","volume":"186","author":"M Selman","year":"2012","unstructured":"Selman\u00a0M, Pardo\u00a0A, King\u00a0TE Jr. (2012) Hypersensitivity pneumonitis: insights in diagnosis and pathobiology. Am J Respir Crit Care Med 186(4):314\u2013324","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"1911_CR37","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1378\/chest.12-2623","volume":"144","author":"JJ Mooney","year":"2013","unstructured":"Mooney\u00a0JJ, Elicker\u00a0BM, Urbania\u00a0TH, Agarwal\u00a0MR, Ryerson\u00a0CJ, Nguyen\u00a0MLT et\u00a0al (2013) Radiographic fibrosis score predicts survival in hypersensitivity pneumonitis. Chest 144(2):586\u2013592","journal-title":"Chest"},{"key":"1911_CR38","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.02776-2021","author":"P Spagnolo","year":"2022","unstructured":"Spagnolo\u00a0P, Bonniaud\u00a0P, Rossi\u00a0G, Sverzellati\u00a0N, Cottin\u00a0V (2022) Drug-induced interstitial lung disease. Eur Respir\u00a0J. https:\/\/doi.org\/10.1183\/13993003.02776-2021","journal-title":"Eur Respir J"},{"issue":"2","key":"1911_CR39","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1007\/s10787-023-01191-3","volume":"31","author":"D Fesu","year":"2023","unstructured":"Fesu\u00a0D, Polivka\u00a0L, Barczi\u00a0E, Foldesi\u00a0M, Horvath\u00a0G, Hidvegi\u00a0E et\u00a0al (2023) Post-COVID interstitial lung disease in symptomatic patients after COVID-19 disease. Inflammopharmacol 31(2):565\u2013571","journal-title":"Inflammopharmacol"},{"key":"1911_CR40","doi-asserted-by":"publisher","DOI":"10.3390\/cells12182238","author":"J Johnston","year":"2023","unstructured":"Johnston\u00a0J, Dorrian\u00a0D, Linden\u00a0D, Stanel\u00a0SC, Rivera-Ortega\u00a0P, Chaudhuri\u00a0N (2023) Pulmonary sequelae of COVID-19: focus on interstitial lung disease. Cells. https:\/\/doi.org\/10.3390\/cells12182238","journal-title":"Cells"},{"key":"1911_CR41","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0122-2016","author":"R Borie","year":"2017","unstructured":"Borie\u00a0R, Kannengiesser\u00a0C, Sicre de Fontbrune\u00a0F, Gouya\u00a0L, Nathan\u00a0N, Crestani\u00a0B (2017) Management of suspected monogenic lung fibrosis in a\u00a0specialised centre. Eur Respir Rev. https:\/\/doi.org\/10.1183\/16000617.0122-2016","journal-title":"Eur Respir Rev"},{"key":"1911_CR42","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01383-2022","author":"R Borie","year":"2023","unstructured":"Borie\u00a0R, Kannengiesser\u00a0C, Antoniou\u00a0K, Bonella\u00a0F, Crestani\u00a0B, Fabre\u00a0A et\u00a0al (2023) European respiratory society statement on familial pulmonary fibrosis. Eur Respir\u00a0J. https:\/\/doi.org\/10.1183\/13993003.01383-2022","journal-title":"Eur Respir J"},{"issue":"6","key":"1911_CR43","doi-asserted-by":"publisher","first-page":"2034","DOI":"10.1378\/chest.127.6.2034","volume":"127","author":"HL Lee","year":"2005","unstructured":"Lee\u00a0HL, Ryu\u00a0JH, Wittmer\u00a0MH, Hartman\u00a0TE, Lymp\u00a0JF, Tazelaar\u00a0HD et\u00a0al (2005) Familial idiopathic pulmonary fibrosis: clinical features and outcome. Chest 127(6):2034\u20132041","journal-title":"Chest"},{"issue":"1","key":"1911_CR44","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1186\/s12890-019-0895-6","volume":"19","author":"E Krauss","year":"2019","unstructured":"Krauss\u00a0E, Gehrken\u00a0G, Drakopanagiotakis\u00a0F, Tello\u00a0S, Dartsch\u00a0RC, Maurer\u00a0O et\u00a0al (2019) Clinical characteristics of patients with familial idiopathic pulmonary fibrosis (f-IPF). BMC Pulm Med 19(1):130","journal-title":"BMC Pulm Med"},{"issue":"4","key":"1911_CR45","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1164\/rccm.201406-1162OC","volume":"191","author":"JA Kropski","year":"2015","unstructured":"Kropski\u00a0JA, Pritchett\u00a0JM, Zoz\u00a0DF, Crossno\u00a0PF, Markin\u00a0C, Garnett\u00a0ET et\u00a0al (2015) Extensive phenotyping of individuals at risk for familial interstitial pneumonia reveals clues to the pathogenesis of interstitial lung disease. Am J Respir Crit Care Med 191(4):417\u2013426","journal-title":"Am J Respir Crit Care Med"},{"key":"1911_CR46","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.03198-2020","author":"A Justet","year":"2021","unstructured":"Justet\u00a0A, Klay\u00a0D, Porcher\u00a0R, Cottin\u00a0V, Ahmad\u00a0K, Molina Molina\u00a0M et\u00a0al (2021) Safety and efficacy of pirfenidone and nintedanib in patients with idiopathic pulmonary fibrosis and carrying a\u00a0telomere-related gene mutation. Eur Respir\u00a0J. https:\/\/doi.org\/10.1183\/13993003.03198-2020","journal-title":"Eur Respir J"},{"key":"1911_CR47","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.02872-2020","author":"A Adegunsoye","year":"2021","unstructured":"Adegunsoye\u00a0A, Morisset\u00a0J, Newton\u00a0CA, Oldham\u00a0JM, Vittinghoff\u00a0E, Linderholm\u00a0AL et\u00a0al (2021) Leukocyte telomere length and mycophenolate therapy in chronic hypersensitivity pneumonitis. Eur Respir\u00a0J. https:\/\/doi.org\/10.1183\/13993003.02872-2020","journal-title":"Eur Respir J"},{"key":"1911_CR48","doi-asserted-by":"publisher","first-page":"582581","DOI":"10.3389\/fmed.2020.582581","volume":"7","author":"E Radzikowska","year":"2020","unstructured":"Radzikowska\u00a0E (2020) Update on pulmonary Langerhans cell histiocytosis. Front Med 7:582581","journal-title":"Front Med"},{"issue":"5","key":"1911_CR49","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1097\/MCP.0000000000000988","volume":"29","author":"F Jouenne","year":"2023","unstructured":"Jouenne\u00a0F, Benattia\u00a0A, Tazi\u00a0A (2023) Pulmonary Langerhans cell histiocytosis\u2014an update on pathogenesis and treatment. Curr Opin Pulm Med 29(5):451\u2013458","journal-title":"Curr Opin Pulm Med"},{"issue":"11","key":"1911_CR50","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1016\/S2213-2600(21)00228-9","volume":"9","author":"C McCarthy","year":"2021","unstructured":"McCarthy\u00a0C, Gupta\u00a0N, Johnson\u00a0SR, Yu\u00a0JJ, McCormack\u00a0FX (2021) Lymphangioleiomyomatosis: pathogenesis, clinical features, diagnosis, and management. Lancet Respir Med 9(11):1313\u20131327","journal-title":"Lancet Respir Med"},{"issue":"17","key":"1911_CR51","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1056\/NEJMoa1100391","volume":"364","author":"FX McCormack","year":"2011","unstructured":"McCormack\u00a0FX, Inoue\u00a0Y, Moss\u00a0J, Singer\u00a0LG, Strange\u00a0C, Nakata\u00a0K et\u00a0al (2011) Efficacy and safety of sirolimus in lymphangioleiomyomatosis. N\u00a0Engl J Med 364(17):1595\u20131606","journal-title":"N Engl J Med"},{"issue":"1","key":"1911_CR52","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/s13023-023-02686-6","volume":"18","author":"T Geberhiwot","year":"2023","unstructured":"Geberhiwot\u00a0T, Wasserstein\u00a0M, Wanninayake\u00a0S, Bolton\u00a0SC, Dardis\u00a0A, Lehman\u00a0A et\u00a0al (2023) Consensus clinical management guidelines for acid sphingomyelinase deficiency (Niemann-Pick disease types\u00a0A, B and\u00a0A\/B). Orphanet J Rare Dis 18(1):85","journal-title":"Orphanet J Rare Dis"},{"issue":"1","key":"1911_CR53","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s13023-017-0572-x","volume":"12","author":"MM McGovern","year":"2017","unstructured":"McGovern\u00a0MM, Avetisyan\u00a0R, Sanson\u00a0BJ, Lidove\u00a0O (2017) Disease manifestations and burden of illness in patients with acid sphingomyelinase deficiency (ASMD). Orphanet J Rare Dis 12(1):41","journal-title":"Orphanet J Rare Dis"},{"issue":"1","key":"1911_CR54","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/s13023-023-02700-x","volume":"18","author":"RH Lachmann","year":"2023","unstructured":"Lachmann\u00a0RH, Diaz\u00a0GA, Wasserstein\u00a0MP, Armstrong\u00a0NM, Yarramaneni\u00a0A, Kim\u00a0Y et\u00a0al (2023) Olipudase alfa enzyme replacement therapy for acid sphingomyelinase deficiency (ASMD): sustained improvements in clinical outcomes after 6.5\u00a0years of treatment in adults. Orphanet J Rare Dis 18(1):94","journal-title":"Orphanet J Rare Dis"},{"issue":"7","key":"1911_CR55","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1016\/j.gim.2022.03.021","volume":"24","author":"M Wasserstein","year":"2022","unstructured":"Wasserstein\u00a0M, Lachmann\u00a0R, Hollak\u00a0C, Arash-Kaps\u00a0L, Barbato\u00a0A, Gallagher\u00a0RC et\u00a0al (2022) A\u00a0randomized, placebo-controlled clinical trial evaluating olipudase alfa enzyme replacement therapy for chronic acid sphingomyelinase deficiency (ASMD) in adults: one-year results. Genet Med 24(7):1425\u20131436","journal-title":"Genet Med"},{"issue":"12","key":"1911_CR56","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1055\/a-1252-1492","volume":"74","author":"P Haidl","year":"2020","unstructured":"Haidl\u00a0P, Jany\u00a0B, Geiseler\u00a0J, Andreas\u00a0S, Arzt\u00a0M, Dreher\u00a0M et\u00a0al (2020) Guideline for long-term oxygen therapy\u2014S2k-guideline published by the German respiratory society. Pneumologie 74(12):813\u2013841","journal-title":"Pneumologie"},{"key":"1911_CR57","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0100-2018","author":"V Cottin","year":"2019","unstructured":"Cottin\u00a0V, Wollin\u00a0L, Fischer\u00a0A, Quaresma\u00a0M, Stowasser\u00a0S, Harari\u00a0S (2019) Fibrosing interstitial lung diseases: knowns and unknowns. Eur Respir Rev. https:\/\/doi.org\/10.1183\/16000617.0100-2018","journal-title":"Eur Respir Rev"},{"issue":"9","key":"1911_CR58","doi-asserted-by":"publisher","first-page":"e18","DOI":"10.1164\/rccm.202202-0399ST","volume":"205","author":"G Raghu","year":"2022","unstructured":"Raghu\u00a0G, Remy-Jardin\u00a0M, Richeldi\u00a0L, Thomson\u00a0CC, Inoue\u00a0Y, Johkoh\u00a0T et\u00a0al (2022) Idiopathic pulmonary fibrosis (an update) and progressive pulmonary fibrosis in adults: an official ATS\/ERS\/JRS\/ALAT clinical practice guideline. Am J Respir Crit Care Med 205(9):e18\u2013e47","journal-title":"Am J Respir Crit Care Med"},{"issue":"26","key":"1911_CR59","doi-asserted-by":"publisher","first-page":"2518","DOI":"10.1056\/NEJMoa1903076","volume":"380","author":"O Distler","year":"2019","unstructured":"Distler\u00a0O, Highland\u00a0KB, Gahlemann\u00a0M, Azuma\u00a0A, Fischer\u00a0A, Mayes\u00a0MD et\u00a0al (2019) Nintedanib for systemic sclerosis-associated interstitial lung disease. N\u00a0Engl J Med 380(26):2518\u20132528","journal-title":"N Engl J Med"}],"container-title":["Die Innere Medizin"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-025-01911-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00108-025-01911-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-025-01911-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T22:30:21Z","timestamp":1757197821000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00108-025-01911-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,24]]},"references-count":59,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["1911"],"URL":"https:\/\/doi.org\/10.1007\/s00108-025-01911-7","relation":{},"ISSN":["2731-7080","2731-7099"],"issn-type":[{"type":"print","value":"2731-7080"},{"type":"electronic","value":"2731-7099"}],"subject":[],"published":{"date-parts":[[2025,6,24]]},"assertion":[{"value":"7 May 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"G.\u00a0Leuschner und J.\u00a0Behr geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autor\/-innen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}